The addition of five new research scientists takes UAB’s Department of Anesthesiology to new heights.
The “repurposing of verapamil as a beta cell survival therapy in type 1 diabetes” trial will test an approach different from any current diabetes treatment.
It has been more than 30 years since the last major advancement in prostate cancer screening technology, and the latest advancement is now available in the Southeast only at UAB.
Keshav K. Singh, Ph.D., an expert on the roles of mitochondria in cancer, mitochondrial disease and aging, is one of 12 extramural researchers invited to a National Cancer Institute Mitochondrial Information Transfer Strategic Workshop.
Two highly acclaimed cancer researchers, Ravi Bhatia, M.D., and Smita Bhatia, M.D., MPH, will join UAB in January 2015.
Sixteen clinical centers and 30 hospitals will enroll up to 5,700 pregnant women to evaluate the benefits and harms of pharmacologic treatment of mild chronic hypertension in pregnancy.
Investigators from UAB’s Nutrition Obesity Research Center and School of Public Health have been awarded a four-year, $1 million R25 grant to deliver an annual short course on innovative methods to find obesity causes.
UAB Distinguished Professor’s editorial highlights research efforts exploring low-sodium intake guidelines and implications on cardiac disease and mortality.
National and international groups select UAB research paper as the year’s best basic science paper for research into urgency urinary incontinence.
Boni Elewski, M.D., led one of two trials featured in the New England Journal of Medicine that show secukinumab is a safe and effective psoriasis treatment.